Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose comparison for prevention of emergence agitation after pediatric tonsillectomy
IRCT20200612047740N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in Emergence agitation (EA) (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Emergence agitation. Started Jul 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on IRCT20200612047740N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200612047740N2.